HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology-Reference-Cited by-同舟云学术

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

Published:2017-01 Issue:1 Volume:13 Page:53-57
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Bartley Angela N.¹,Washington Mary Kay¹,Ismaila Nofisat¹,Ajani Jaffer A.¹

Affiliation:

1. St Joseph Mercy Hospital, Ann Arbor, MI; Vanderbilt University Medical Center, Nashville, TN; American Society of Clinical Oncology, Alexandria, VA; MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2016.018929

Reference13 articles.

1. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

2. The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase Activity

3. Novel targeted agents for gastric cancer

4. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

5. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best practices for achieving consensus in HER2‐low expression in breast cancer: current perspectives from practising pathologists;Histopathology;2024-07-08

2. Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives;Journal of Clinical Medicine;2023-07-12

3. The “Light Knife” for Gastric Cancer: Photodynamic Therapy;Pharmaceutics;2022-12-28

4. Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer;Journal of Cancer Research and Clinical Oncology;2022-05-13

5. The potential of mRNA expression evaluation in predicting HER2 positivity in gastroesophageal cancer;Brazilian Journal of Medical and Biological Research;2022